Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01189 (
beta-endorphin
)
21,003
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Pro-opiomelanocortin
(
POMC
) expressing neurons mediate the regulation of orexigenic drive by peripheral hormones such as leptin, cholecystokinin,
ghrelin
, and insulin. Most research effort has focused on
alpha-melanocyte-stimulating hormone
(
alpha-MSH
) as the predominant
POMC
-derived neuropeptide in the central regulation of human energy balance and body weight. Here we report a missense mutation within the coding region of the
POMC
-derived peptide
beta-MSH
(Y5C-
beta-MSH
) and its association with early-onset human obesity. In vitro and in vivo data as well as postmortem human brain studies indicate that the
POMC
-derived neuropeptide
beta-MSH
plays a critical role in the hypothalamic control of body weight in humans.
...
PMID:A role for beta-melanocyte-stimulating hormone in human body-weight regulation. 1645 7
Peripheral feeding-related hormones such as leptin, insulin, and
ghrelin
exert their main central effects through neuropeptide Y- (NPY) synthesizing and
alpha-melanocyte-stimulating hormone
- (alpha-MSH) synthesizing neurons of the hypothalamic arcuate nucleus. In rodents, recent reports have described an asymmetric signaling between these neuron populations by showing that while NPY influences alpha-MSH-synthesizing neurons, the melanocortin-receptor agonist Melanotan II (MTII) does not modulate the electrophysiological properties of NPY neurons. The functional neuroanatomy of the relationship between these cell populations is unknown in humans. The aim of the current study was to analyze the putative relationship of the orexigenic NPY and anorexigenic alpha-MSH systems in the infundibular nucleus of the human hypothalamus, the analogue of the rodent arcuate nucleus. Double-labeling fluorescent immunocytochemistry for NPY and alpha-MSH was performed on postmortem sections of the human hypothalamus. The sections were analyzed by confocal laser microscopy. Both NPY- and alpha-MSH-immunoreactive (IR) neurons were embedded in dense, intermingling networks of NPY- and alpha-MSH-IR axons in the human infundibular nucleus. NPY-IR varicosities were observed in juxtaposition to all alpha-MSH-IR neurons. The mean number of NPY-IR axon varicosities on the surface of an alpha-MSH-IR neuron was approximately six. The majority of NPY-IR neurons were also contacted by alpha-MSH-IR varicosities, although, the number of such contacts was lower (two alpha-MSH-IR varicosities per NPY neuron). In summary, the present data demonstrate that these two antagonistic, feeding-related neuronal systems are interconnected in the infundibular nucleus, and the neuronal wiring possesses an asymmetric character in the human hypothalamus.
...
PMID:Interconnection between orexigenic neuropeptide Y- and anorexigenic alpha-melanocyte stimulating hormone-synthesizing neuronal systems of the human hypothalamus. 1647 35
Ghrelin is an orexigenic peptide involved in the regulation of energy homeostasis. To investigate the role of
ghrelin
in the hyperphagia associated with uncontrolled streptozotocin-induced diabetes, food intake was followed in diabetic
ghrelin
knockout (
ghrelin
(-/-)) and control wild-type (
ghrelin
(+/+)) mice and diabetic Naval Medical Research Institute noninbred Swiss mice treated with either saline or the ghrelin receptor antagonist, D-Lys3-GH-releasing peptide-6 (D-Lys3-GHRP-6) for 5 d. In diabetic
ghrelin
(-/-) mice, hyperphagia was attenuated, and the maximal increase in food intake was 50% lower in mutant than in wild-type mice. The increased food intake observed during the light period (1000-1200 h) in
ghrelin
(+/+) mice was abolished in mutant mice. Diabetic
ghrelin
(-/-) mice lost 12.4% more body weight than
ghrelin
(+/+) mice. In diabetic
ghrelin
(+/+) mice, but not in
ghrelin
(-/-) mice, the number of neuropeptide Y (NPY)-immunoreactive neurons was significantly increased. Diabetic Naval Medical Research Institute noninbred Swiss mice were hyperphagic and had increased plasma
ghrelin
levels. Treatment with D-Lys3-GHRP-6 reduced daily food intake by 23% and reversed the increased food intake observed during the light period. The change in the number of NPY- (2.4-fold increase) and
alpha-MSH
(1.7-fold decrease)-immunoreactive hypothalamic neurons induced by diabetes was normalized by D-Lys3-GHRP-6 treatment. Our results suggest that enhanced NPY and reduced
alpha-MSH
expression are secondary to the release of
ghrelin
, which should be considered the underlying trigger of hyperphagia associated with uncontrolled diabetes.
...
PMID:Role of endogenous ghrelin in the hyperphagia of mice with streptozotocin-induced diabetes. 1670 31
The action of
ghrelin
on telemetrically recorded motor activity and the transmission of the effects of this neuropeptide on spontaneous and exploratory motor activity and some related endocrine and homeostatic parameters were investigated. Different doses (0.5-5 microg) of
ghrelin
administered intracerebroventricularly caused significant increases in both square crossing and rearing activity in the "open-field" apparatus, while only the dose of 5 microg evoked a significant increase in the spontaneous locomotor activity recorded by telemetry. Ghrelin also induced significant increases in corticosterone release and core temperature. To determine the transmission of these neuroendocrine actions, the rats were pretreated with different antagonists, such as a
corticotropin
-releasing hormone (CRH) antagonist (alpha-helical CRH(9-41)), the nitric oxide synthase inhibitor Nomega-nitro-L-arginine-methyl ester (L-NAME), haloperidol, cyproheptadine or the cyclooxygenase inhibitor noraminophenazone (NAP). The open-field and biotelemetric observations revealed that the motor responses were diminished by pretreatment with the CRH antagonist and haloperidol. In the case of HPA (hypothalamic pituitary adrenal) activation, only cyproheptadine pretreatment proved effective; haloperidol and L-NAME did not modify the corticosterone response. NAP had only a transient, while cyproheptadine elicited a more permanent impact on the hyperthermic response evoked by
ghrelin
; the other antagonists proved to be ineffective. The present data suggest that both CRH release and dopaminergic transmission may be involved in the
ghrelin
-evoked behavioral responses. On the other hand,
ghrelin
appears to have an impact on the HPA response via a serotonergic pathway and on the hyperthermic response via a cyclooxygenase and a serotonergic pathway.
...
PMID:Mediation of the behavioral, endocrine and thermoregulatory actions of ghrelin. 1664 13
This review summarizes recent developments in the field of sleep regulation, particularly in the role of hormones, and of synthetic GABA(A) receptor agonists. Certain hormones play a specific role in sleep regulation. A reciprocal interaction of the neuropeptides growth hormone (GH)-releasing hormone (GHRH) and
corticotropin
-releasing hormone (CRH) plays a key role in sleep regulation. At least in males GHRH is a common stimulus of non-rapid-eye-movement sleep (NREMS) and GH and inhibits the hypothalamo-pituitary adrenocortical (HPA) hormones, whereas CRH exerts opposite effects. Furthermore CRH may enhance rapid-eye-movement sleep (REMS). Changes in the GHRH:CRH ratio in favor of CRH appear to contribute to sleep EEG and endocrine changes during depression and normal ageing. In women, however, CRH-like effects of GHRH were found. Besides CRH somatostatin impairs sleep, whereas
ghrelin
, galanin and neuropeptide Y promote sleep. Vasoactive intestinal polypeptide appears to be involved in the temporal organization of human sleep. Beside of peptides, steroids participate in sleep regulation. Cortisol appears to promote REMS. Various neuroactive steroids exert specific effects on sleep. The beneficial effect of estrogen replacement therapy in menopausal women suggests a role of estrogen in sleep regulation. The GABA(A) receptor or GABAergic neurons are involved in the action of many of these hormones. Recently synthetic GABA(A) agonists, particularly gaboxadol and the GABA reuptake inhibitor tiagabine were shown to differ distinctly in their action from allosteric modulators of the GABA(A) receptor like benzodiazepines as they promote slow-wave sleep, decrease wakefulness and do not affect REMS.
...
PMID:Neurochemical regulation of sleep. 1677 43
Corticosterone and total
ghrelin
levels are increased in somatostatin (SST) knockout mice (Sst-/-) compared with SST-intact controls (Sst+/+). Because exogenous
ghrelin
can increase glucocorticoids, the question arises whether elevated levels of
ghrelin
contribute to elevated corticosterone levels in Sst-/- mice. We report that Sst-/- mice had elevated mRNA levels for pituitary proopiomelanocortin (POMC), the precursor of
adrenocorticotropic hormone (ACTH)
, whereas mRNA levels for hypothalamic
corticotropin
-releasing hormone (CRH) did not differ from Sst+/+ mice. Furthermore, SST suppressed pituitary POMC mRNA levels and ACTH release in vitro independently of CRH actions. In contrast, it has been reported that
ghrelin
increases glucocorticoids via a central effect on CRH secretion and that n-octanoyl
ghrelin
is the form of
ghrelin
that activates the GHS-R1a and modulates CRH neuronal activity. Consistent with elevations in total
ghrelin
levels, Sst-/- mice displayed an increase in stomach
ghrelin
mRNA levels, whereas hypothalamic and pituitary expression of
ghrelin
was not altered. Despite the increase in total
ghrelin
levels, circulating levels of n-octanoyl
ghrelin
were not altered in Sst-/- mice. Because glucocorticoids and
ghrelin
increase in response to fasting, we examined the impact of fasting on the adrenal axis and
ghrelin
in Sst+/+ and Sst-/- mice and found that endogenous SST does not significantly contribute to this adaptive response. We conclude that endogenous SST inhibits basal
ghrelin
gene expression in a tissue specific manner and independently and directly inhibits pituitary ACTH synthesis and release. Thus endogenous SST exerts an inhibitory effect on
ghrelin
synthesis and on the adrenal axis through independent pathways.
...
PMID:Evidence that endogenous SST inhibits ACTH and ghrelin expression by independent pathways. 1682 6
A number of different neuropeptides exert powerful concerted controls on feeding behavior and energy balance, most of them being produced in hypothalamic neuronal networks under stimulation by anabolic and catabolic peripheral hormones such as
ghrelin
and leptin, respectively. These peptide-expressing neurons interconnect extensively to integrate the multiple opposing signals that mediate changes in energy expenditure. In the present review I have summarized our current knowledge about two key peptidic systems involved in regulating appetite and energy homeostasis, the melanocortin system (
alpha-MSH
, agouti and Agouti-related peptides, MC receptors and mahogany protein) and the melanin-concentrating hormone system (proMCH-derived peptides and MCH receptors) that contribute to satiety and feeding-initiation, respectively, with concurrent effects on energy expenditure. I have focused particularly on recent data concerning transgenic mice and the ongoing development of MC/MCH receptor antagonists/agonists that may represent promising drugs to treat human eating disorders on both sides of the energy balance (anorexia, obesity).
...
PMID:The melanocortins and melanin-concentrating hormone in the central regulation of feeding behavior and energy homeostasis. 1686 Feb 80
Regulation of energy homeostasis requires precise coordination between peripheral nutrient-sensing molecules and central regulatory networks. Ghrelin is a twenty-eight-amino acid orexigenic peptide acylated at the serine 3 position mainly with an n-octanoic acid, which is produced mainly in the stomach. It is the endogenous ligand of the growth hormone secretagogue (GHS) receptors. Since plasma
ghrelin
levels are strictly dependent on recent food intake, this hormone plays an essential role in appetite and meal initiation. In addition,
ghrelin
is involved in the regulation of energy homeostasis. The
ghrelin
gene is composed of four exons and three introns and renders a diversity of orexigenic peptides as well as des-acyl
ghrelin
and obestatin, which exhibit anorexigenic properties. Ghrelin stimulates the synthesis of neuropeptide Y (NPY) and agouti-related protein (AgRP) in the arcuate nucleus neurons of the hypothalamus and hindbrain, which in turn enhance food intake. Ghrelin-expressing neurons modulate the action of both orexigenic NPY/AgRP and anorexigenic pro-
opiomelanocortin
neurons. AMP-activated protein kinase is activated by
ghrelin
in the hypothalamus, which contributes to lower intracellular long-chain fatty acids, and this appears to be the molecular signal for the expression of NPY and AgRP. Recent data suggest that
ghrelin
has an important role in the regulation of leptin and insulin secretion and vice versa. The present paper updates the effects of
ghrelin
on the control of energy homeostasis and reviews the molecular mechanisms of
ghrelin
synthesis, as well as interaction with GHS receptors and signalling. Relationships with leptin and insulin in the regulation of energy homeostasis are addressed.
...
PMID:Ghrelin: a hormone regulating food intake and energy homeostasis. 1692 14
Ghrelin is a brain-gut peptide known for its growth hormone (GH)-releasing and appetite-inducing activities. This natural GH secretagogue (GHS) was originally purified from rat stomach, but it is expressed widely in different tissues where it may have endocrine and paracrine effects. The central effects of
ghrelin
on
adrenocorticotropic hormone (ACTH)
cells, ACTH release and subsequent corticosterone release from adrenal glands remains to be clarified. The aim of this study was to specifically determine the morphological features of ACTH-producing pituicytes and blood concentration of ACTH and corticosterone after central administration of
ghrelin
. Five doses of rat
ghrelin
or PBS (n=10 per group) were injected every 24 h (1 microg of
ghrelin
in 5 muL PBS), into the lateral cerebral ventricle of male rats. Results showed that
ghrelin
increased (p<0.05) absolute and relative pituitary weights compared to controls (58% and 41% respectively). Morphometric parameters, i.e. the volume of the ACTH cells, nuclear volume, and volume density were all increased (p<0.05), by 17%, 6% and 13%, respectively, 2 h after the last
ghrelin
treatment. Ghrelin increased circulating concentrations of ACTH and corticosterone (p<0.05) by 62% and 66%, respectively. The data provide clear documentation that intracerebroventricular
ghrelin
stimulates ACTH cell hypertrophy and proliferation, and promotes ACTH and corticosterone release. Determining the role of
ghrelin
in physiological stress responses and whether control of the peptide's activity would be useful for prevention and/or treatment of stress-induced diseases remain important research goals.
...
PMID:The effect of centrally administered ghrelin on pituitary ACTH cells and circulating ACTH and corticosterone in rats. 1715 27
This study aimed to clarify the interaction of tumor necrosis factor-alpha (TNF-alpha), an anorexigenic cytokine, with
ghrelin
, an orexigenic peptide secreted by the stomach lining, and hypothalamic neuropeptides in the regulation of food intake in mice. The peripheral administration of TNF-alpha dose-dependently decreased the 24-h cumulative food intake compared with the administration of saline. Reduced food intake was observed at 6 h and 24 h. The same TNF-alpha treatment significantly decreased the plasma level of
ghrelin
at 6 h and 24 h after treatment compared with the control levels. These changes were accompanied by a significant reduction in the expression of
ghrelin
mRNA in the stomach at 24 h after treatment. TNF-alpha treatment also resulted in a significant increase in expression of
pro-opiomelanocortin (POMC)
mRNA and a significant decrease in expression of agouti-related protein (AGRP) mRNA in the hypothalamus at 6 h after treatment. Finally, the pre-administration of
ghrelin
, reversed the TNF-alpha-induced hypophagia in mice at 6 and 24 h. Taken together, these findings suggest that hypothalamic POMC and AGRP and stomach
ghrelin
may be involved in TNF-alpha-induced hypophagia in mice.
...
PMID:Involvement of stomach ghrelin and hypothalamic neuropeptides in tumor necrosis factor-alpha-induced hypophagia in mice. 1718 75
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>